Report cover image

Global China PD-L1 and PIK3CA Testing Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 192 Pages
SKU # APRC20360989

Description

Summary

According to APO Research, The global China PD-L1 and PIK3CA Testing market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for China PD-L1 and PIK3CA Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for China PD-L1 and PIK3CA Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for China PD-L1 and PIK3CA Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for China PD-L1 and PIK3CA Testing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of China PD-L1 and PIK3CA Testing include Agilent Technologies, EntroGen, QIAGEN, Amoy Diagnostics, Roche and ACCB Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for China PD-L1 and PIK3CA Testing, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of China PD-L1 and PIK3CA Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for China PD-L1 and PIK3CA Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the China PD-L1 and PIK3CA Testing revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global China PD-L1 and PIK3CA Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for China PD-L1 and PIK3CA Testing revenue, projected growth trends, production technology, application and end-user industry.

China PD-L1 and PIK3CA Testing Segment by Company

Agilent Technologies
EntroGen
QIAGEN
Amoy Diagnostics
Roche
ACCB Biotech
China PD-L1 and PIK3CA Testing Segment by Type

PD-L1 Testing
PIK3CA Testing
China PD-L1 and PIK3CA Testing Segment by Application

Hospital
Diagnostic Center
Others
China PD-L1 and PIK3CA Testing Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global China PD-L1 and PIK3CA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of China PD-L1 and PIK3CA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of China PD-L1 and PIK3CA Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of China PD-L1 and PIK3CA Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of China PD-L1 and PIK3CA Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, China PD-L1 and PIK3CA Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 China PD-L1 and PIK3CA Testing Market by Type
1.2.1 Global China PD-L1 and PIK3CA Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 PD-L1 Testing
1.2.3 PIK3CA Testing
1.3 China PD-L1 and PIK3CA Testing Market by Application
1.3.1 Global China PD-L1 and PIK3CA Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 China PD-L1 and PIK3CA Testing Market Dynamics
2.1 China PD-L1 and PIK3CA Testing Industry Trends
2.2 China PD-L1 and PIK3CA Testing Industry Drivers
2.3 China PD-L1 and PIK3CA Testing Industry Opportunities and Challenges
2.4 China PD-L1 and PIK3CA Testing Industry Restraints
3 Global Growth Perspective
3.1 Global China PD-L1 and PIK3CA Testing Market Perspective (2020-2031)
3.2 Global China PD-L1 and PIK3CA Testing Growth Trends by Region
3.2.1 Global China PD-L1 and PIK3CA Testing Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global China PD-L1 and PIK3CA Testing Market Size by Region (2020-2025)
3.2.3 Global China PD-L1 and PIK3CA Testing Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global China PD-L1 and PIK3CA Testing Revenue by Players
4.1.1 Global China PD-L1 and PIK3CA Testing Revenue by Players (2020-2025)
4.1.2 Global China PD-L1 and PIK3CA Testing Revenue Market Share by Players (2020-2025)
4.1.3 Global China PD-L1 and PIK3CA Testing Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global China PD-L1 and PIK3CA Testing Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global China PD-L1 and PIK3CA Testing Key Players Headquarters & Area Served
4.4 Global China PD-L1 and PIK3CA Testing Players, Product Type & Application
4.5 Global China PD-L1 and PIK3CA Testing Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global China PD-L1 and PIK3CA Testing Market CR5 and HHI
4.6.3 2024 China PD-L1 and PIK3CA Testing Tier 1, Tier 2, and Tier 3
5 China PD-L1 and PIK3CA Testing Market Size by Type
5.1 Global China PD-L1 and PIK3CA Testing Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global China PD-L1 and PIK3CA Testing Revenue by Type (2020-2031)
5.3 Global China PD-L1 and PIK3CA Testing Revenue Market Share by Type (2020-2031)
6 China PD-L1 and PIK3CA Testing Market Size by Application
6.1 Global China PD-L1 and PIK3CA Testing Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global China PD-L1 and PIK3CA Testing Revenue by Application (2020-2031)
6.3 Global China PD-L1 and PIK3CA Testing Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Comapny Information
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
7.1.4 Agilent Technologies China PD-L1 and PIK3CA Testing Product Portfolio
7.1.5 Agilent Technologies Recent Developments
7.2 EntroGen
7.2.1 EntroGen Comapny Information
7.2.2 EntroGen Business Overview
7.2.3 EntroGen China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
7.2.4 EntroGen China PD-L1 and PIK3CA Testing Product Portfolio
7.2.5 EntroGen Recent Developments
7.3 QIAGEN
7.3.1 QIAGEN Comapny Information
7.3.2 QIAGEN Business Overview
7.3.3 QIAGEN China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
7.3.4 QIAGEN China PD-L1 and PIK3CA Testing Product Portfolio
7.3.5 QIAGEN Recent Developments
7.4 Amoy Diagnostics
7.4.1 Amoy Diagnostics Comapny Information
7.4.2 Amoy Diagnostics Business Overview
7.4.3 Amoy Diagnostics China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
7.4.4 Amoy Diagnostics China PD-L1 and PIK3CA Testing Product Portfolio
7.4.5 Amoy Diagnostics Recent Developments
7.5 Roche
7.5.1 Roche Comapny Information
7.5.2 Roche Business Overview
7.5.3 Roche China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
7.5.4 Roche China PD-L1 and PIK3CA Testing Product Portfolio
7.5.5 Roche Recent Developments
7.6 ACCB Biotech
7.6.1 ACCB Biotech Comapny Information
7.6.2 ACCB Biotech Business Overview
7.6.3 ACCB Biotech China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2020-2025)
7.6.4 ACCB Biotech China PD-L1 and PIK3CA Testing Product Portfolio
7.6.5 ACCB Biotech Recent Developments
8 North America
8.1 North America China PD-L1 and PIK3CA Testing Revenue (2020-2031)
8.2 North America China PD-L1 and PIK3CA Testing Revenue by Type (2020-2031)
8.2.1 North America China PD-L1 and PIK3CA Testing Revenue by Type (2020-2025)
8.2.2 North America China PD-L1 and PIK3CA Testing Revenue by Type (2026-2031)
8.3 North America China PD-L1 and PIK3CA Testing Revenue Share by Type (2020-2031)
8.4 North America China PD-L1 and PIK3CA Testing Revenue by Application (2020-2031)
8.4.1 North America China PD-L1 and PIK3CA Testing Revenue by Application (2020-2025)
8.4.2 North America China PD-L1 and PIK3CA Testing Revenue by Application (2026-2031)
8.5 North America China PD-L1 and PIK3CA Testing Revenue Share by Application (2020-2031)
8.6 North America China PD-L1 and PIK3CA Testing Revenue by Country
8.6.1 North America China PD-L1 and PIK3CA Testing Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America China PD-L1 and PIK3CA Testing Revenue by Country (2020-2025)
8.6.3 North America China PD-L1 and PIK3CA Testing Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe China PD-L1 and PIK3CA Testing Revenue (2020-2031)
9.2 Europe China PD-L1 and PIK3CA Testing Revenue by Type (2020-2031)
9.2.1 Europe China PD-L1 and PIK3CA Testing Revenue by Type (2020-2025)
9.2.2 Europe China PD-L1 and PIK3CA Testing Revenue by Type (2026-2031)
9.3 Europe China PD-L1 and PIK3CA Testing Revenue Share by Type (2020-2031)
9.4 Europe China PD-L1 and PIK3CA Testing Revenue by Application (2020-2031)
9.4.1 Europe China PD-L1 and PIK3CA Testing Revenue by Application (2020-2025)
9.4.2 Europe China PD-L1 and PIK3CA Testing Revenue by Application (2026-2031)
9.5 Europe China PD-L1 and PIK3CA Testing Revenue Share by Application (2020-2031)
9.6 Europe China PD-L1 and PIK3CA Testing Revenue by Country
9.6.1 Europe China PD-L1 and PIK3CA Testing Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe China PD-L1 and PIK3CA Testing Revenue by Country (2020-2025)
9.6.3 Europe China PD-L1 and PIK3CA Testing Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China China PD-L1 and PIK3CA Testing Revenue (2020-2031)
10.2 China China PD-L1 and PIK3CA Testing Revenue by Type (2020-2031)
10.2.1 China China PD-L1 and PIK3CA Testing Revenue by Type (2020-2025)
10.2.2 China China PD-L1 and PIK3CA Testing Revenue by Type (2026-2031)
10.3 China China PD-L1 and PIK3CA Testing Revenue Share by Type (2020-2031)
10.4 China China PD-L1 and PIK3CA Testing Revenue by Application (2020-2031)
10.4.1 China China PD-L1 and PIK3CA Testing Revenue by Application (2020-2025)
10.4.2 China China PD-L1 and PIK3CA Testing Revenue by Application (2026-2031)
10.5 China China PD-L1 and PIK3CA Testing Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia China PD-L1 and PIK3CA Testing Revenue (2020-2031)
11.2 Asia China PD-L1 and PIK3CA Testing Revenue by Type (2020-2031)
11.2.1 Asia China PD-L1 and PIK3CA Testing Revenue by Type (2020-2025)
11.2.2 Asia China PD-L1 and PIK3CA Testing Revenue by Type (2026-2031)
11.3 Asia China PD-L1 and PIK3CA Testing Revenue Share by Type (2020-2031)
11.4 Asia China PD-L1 and PIK3CA Testing Revenue by Application (2020-2031)
11.4.1 Asia China PD-L1 and PIK3CA Testing Revenue by Application (2020-2025)
11.4.2 Asia China PD-L1 and PIK3CA Testing Revenue by Application (2026-2031)
11.5 Asia China PD-L1 and PIK3CA Testing Revenue Share by Application (2020-2031)
11.6 Asia China PD-L1 and PIK3CA Testing Revenue by Country
11.6.1 Asia China PD-L1 and PIK3CA Testing Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia China PD-L1 and PIK3CA Testing Revenue by Country (2020-2025)
11.6.3 Asia China PD-L1 and PIK3CA Testing Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA China PD-L1 and PIK3CA Testing Revenue (2020-2031)
12.2 SAMEA China PD-L1 and PIK3CA Testing Revenue by Type (2020-2031)
12.2.1 SAMEA China PD-L1 and PIK3CA Testing Revenue by Type (2020-2025)
12.2.2 SAMEA China PD-L1 and PIK3CA Testing Revenue by Type (2026-2031)
12.3 SAMEA China PD-L1 and PIK3CA Testing Revenue Share by Type (2020-2031)
12.4 SAMEA China PD-L1 and PIK3CA Testing Revenue by Application (2020-2031)
12.4.1 SAMEA China PD-L1 and PIK3CA Testing Revenue by Application (2020-2025)
12.4.2 SAMEA China PD-L1 and PIK3CA Testing Revenue by Application (2026-2031)
12.5 SAMEA China PD-L1 and PIK3CA Testing Revenue Share by Application (2020-2031)
12.6 SAMEA China PD-L1 and PIK3CA Testing Revenue by Country
12.6.1 SAMEA China PD-L1 and PIK3CA Testing Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA China PD-L1 and PIK3CA Testing Revenue by Country (2020-2025)
12.6.3 SAMEA China PD-L1 and PIK3CA Testing Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.